Mc Adam, LLC Amgen Inc Transaction History

Mc Adam, LLC

$1.65 Billion
Q2 2024

A detailed history of Mc Adam, LLC transactions in Amgen Inc stock. As of the latest transaction made, Mc Adam, LLC holds 810 shares of AMGN stock, worth $269,284. This represents 0.02% of its overall portfolio holdings.

Number of Shares

810

Previous 750 8.0%

Holding current value

$269,284

Previous $213,000 18.78%

% of portfolio

0.02%

Previous 0.01%

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 24, 2024	BUY	$262.75 - $319.31 $15,765 - $19,158	60 Added 8.0%	810 $253,000
Q1 2024 Apr 23, 2024	BUY	$268.87 - $324.56 $7,528 - $9,087	28 Added 3.88%	750 $213,000
Q4 2023 Feb 05, 2024	BUY	$255.7 - $288.46 $184,615 - $208,268	722 New	722 $207,000
Q2 2023 Aug 02, 2023	BUY	$214.27 - $253.37 $341,117 - $403,365	1,592 New	1,592 $353,000
Q4 2018 Jan 30, 2019	SELL	$178.4 - $208.25 $62,975 - $73,512	-353 Closed	0 $0
Q2 2018 Aug 22, 2018	BUY	$166.05 - $186.51 $5,479 - $6,154	33 Added 10.31%	353 $65,000
Q1 2018 Apr 24, 2018	BUY	$169.43 - $198.0 $54,217 - $63,360	320 New	320 $55,000

Others Institutions Holding AMGN

# of Institutions

3,054

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.26M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $178B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mc Adam, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mc Adam, LLC with notifications on news.

Account